| Target Price | $559.98 |
| Price | $512.16 |
| Potential |
9.34%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Chemed Corporation 2027 .
The average Chemed Corporation target price is $559.98.
This is
9.34%
register free of charge
$619.50
20.96%
register free of charge
$525.20
2.55%
register free of charge
|
|
| A rating was issued by 8 analysts: 4 Analysts recommend Chemed Corporation to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Chemed Corporation stock has an average upside potential 2027 of
9.34%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.53 | 2.75 |
| 4.06% | 8.62% | |
| EBITDA Margin | 16.69% | 18.98% |
| 13.73% | 13.74% | |
| Net Margin | 10.48% | 12.21% |
| 15.60% | 16.46% |
5 Analysts have issued a sales forecast Chemed Corporation 2026 . The average Chemed Corporation sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Chemed Corporation EBITDA forecast 2026. The average Chemed Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Chemed Corporation Analysts have issued a net profit forecast 2026. The average Chemed Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 18.34 | 25.78 |
| 7.79% | 40.57% | |
| P/E | 19.87 | |
| EV/Sales | 2.48 |
5 Analysts have issued a Chemed Corporation forecast for earnings per share. The average Chemed Corporation EPS is
This results in the following potential growth metrics and future valuations:
Chemed Corporation...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 27 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Feb 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


